Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shandong Pharmaceutical Glass Co., Ltd
  6. Summary
    600529   CNE000001BG9

SHANDONG PHARMACEUTICAL GLASS CO., LTD

(600529)
  Report
End-of-day quote Shanghai Stock Exchange  -  2023-02-06
28.40 CNY   -1.29%
2022Shandong Pharmaceutical Glass Co., Ltd announced that it has received CNY 1.866494692 billion in funding
CI
2022Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
2022Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
02/01/2023 02/02/2023 02/03/2023 02/06/2023 02/07/2023 Date
29.37 29.24 29.13 28.77 28.4 Last
7861434 5529152 5283632 6239685 6165696 Volume
+1.63% -0.44% -0.38% -1.24% -1.29% Change
Estimated financial data (e)
Sales 2022 4 322 M 636 M 636 M
Net income 2022 714 M 105 M 105 M
Net cash position 2022 1 968 M 290 M 290 M
P/E ratio 2022 24,2x
Yield 2022 1,19%
Sales 2023 4 926 M 725 M 725 M
Net income 2023 869 M 128 M 128 M
Net cash position 2023 1 829 M 269 M 269 M
P/E ratio 2023 19,9x
Yield 2023 1,50%
Capitalization 18 847 M 2 775 M 2 775 M
EV / Sales 2022 3,90x
EV / Sales 2023 3,45x
Nbr of Employees -
Free-Float 80,5%
More Financials
Company
SHANDONG PHARMACEUTICAL GLASS CO., LTD is a China-based company principally engaged in the research and development, manufacture and distribution of pharmaceutical glass products. The Company's products include molded pharmaceutical glass bottles, ampoules, phials, brown bottles, butyl rubber plugs, aluminum tops and others. The Company distributes its products in domestic and overseas markets. 
Read more
More about the company
Ratings of Shandong Pharmaceutical Glass Co., Ltd
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
D-
More Ratings
All news about SHANDONG PHARMACEUTICAL GLASS CO., LTD
2022Shandong Pharmaceutical Glass Co., Ltd announced that it has received CNY 1.866494692 b..
CI
2022Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months End..
CI
2022Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended..
CI
2022Triumph Science & Technology Co.,Ltd cancelled the acquisition of a 11% stake in Shando..
CI
2022Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the First Quarter E..
CI
2022Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Full Year Ended..
CI
2021Shandong Pharmaceutical Glass Co., Ltd(SHSE:600529)..
CI
2021Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months End..
CI
2021Shandong Pharmaceutical Glass Co., Ltd announced that it expects to receive CNY 1.86649..
CI
2021Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended..
CI
2021Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Fourth Quarter ..
CI
2020Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Nine Months End..
CI
2020Shandong Pharmaceutical Glass Co., Ltd(XSSC:600529)..
CI
2020Shandong Pharmaceutical Glass Co., Ltd(XSSC:600529)..
CI
2020Shandong Pharmaceutical Glass Co., Ltd Reports Earnings Results for the Half Year Ended..
CI
More news
News in other languages on SHANDONG PHARMACEUTICAL GLASS CO., LTD
2022Shandong Pharmaceutical Glass Co., Ltd annonce ses résultats pour les neuf mois terminé..
2022Shandong Pharmaceutical Glass Co., Ltd. annonce ses résultats pour le semestre clos le ..
2022Triumph Science & Technology Co.,Ltd (SHSE:600552) ..
2022La société Shandong Pharmaceutical Glass Co., Ltd. annonce ses résultats financiers pou..
2022Shandong Pharmaceutical Glass Co., Ltd. annonce ses résultats financiers pour l'année c..
More news
ETFs positioned on SHANDONG PHARMACEUTICAL GLASS CO., LTDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
China Southern SSE 380 Index ETF - CNY0.37%-0.10%-China
Xtrackers Harvest CSI 500 China-A Shares Sm...0.24%-0.39%China
Franklin FTSE China ETF - USD0.01%-3.94%China
Franklin FTSE Asia ex Japan ETF - USD0.01%-2.76%Asia
SPDR FTSE Greater China ETF - HKD0.01%-2.87%-China
More ETFs positioned on SHANDONG PHARMACEUTICAL GLASS CO., LTD
Chart SHANDONG PHARMACEUTICAL GLASS CO., LTD
Duration : Period :
Shandong Pharmaceutical Glass Co., Ltd Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SHANDONG PHARMACEUTICAL GLASS CO., LTD
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 28,40 CNY
Average target price 36,56 CNY
Spread / Average Target 28,7%
EPS Revisions
Managers and Directors
Jun Zhang General Manager & Director
Yi Zhao Song Chief Financial Officer & Director
Wen Chai Chairman-Supervisory Board
Yong Gang Hu Chairman
Hong Cai Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SHANDONG PHARMACEUTICAL GLASS CO., LTD0.00%2 775
COLOPLAST A/S1.87%25 329
SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED1.87%7 607
NAKANISHI INC.6.96%1 755
ZHEJIANG GONGDONG MEDICAL TECHNOLOGY CO.,LTD.-2.37%1 728
TOP GLOVE CORPORATION BHD.-7.18%1 598